University of California, San Diego (UCSD)
9500 Gilman Drive
La Jolla
California
92093-0093
United States
Tel: 858-534-2230
Website: http://www.ucsd.edu/
Email: feedback@ucsd.edu
559 articles about University of California, San Diego (UCSD)
-
At AAIC, researchers presented studies using CRISPR-Cas9 in animal/organoid models of Alzheimer’s disease, but some experts doubt that such approaches will successfully translate to humans.
-
Arcutis scoops up Ducentis and its lead asset DS-234, UC San Diego receives $150M earmarked for stem cell, regenerative medicine research and Arsenal and ILiAD reel in new funds.
-
Covid-19, aging, stroke, ALS, colorectal cancers and Alzheimer's disease are all the focus of this week's top research stories.
-
Facing the looming threat of AMR, researchers finally have a new clue as to why attempts to develop an effective S. aureus vaccine have failed. BioSpace spoke with the team leaders.
-
Researchers and biotech companies are working on developing vaccines and therapies for cancer, ALS, COVID-19, obesity and psoriasis. Here's a look at just some of them.
-
A new study on gut microbiome activity suggests that diet and eating schedules may affect the body's propensity to become obese and unhealthy.
-
Researchers at the University of California, San Diego published promising preclinical work on a new combination therapy to treat colon cancer.
-
May has been fruitful for research into the prevention and diagnosis of Alzheimer’s disease, the mechanisms behind early symptoms and potential treatments.
-
A team at the University of California, San Diego developed a drug screening method to help determine why Alzheimer’s drugs fail. The system analyzes disease mechanisms in human neurons.
-
Latest Kyoto Prize Laureates to Share Stories of Life and Innovation, Free to Public, March 30-31 (PDT)
3/28/2022
The 21st annual Kyoto Prize Symposium this week celebrates the three latest laureates of the Kyoto Prize, Japan's highest private award for global achievement, during live and online events co-hosted by University of California, San Diego and Point Loma Nazarene University.
-
Vektor Medical Announces University of California, San Diego Health as World’s First Hospital System to Offer vMap for Cardiac Ablation Mapping
2/14/2022
Vektor Medical, Inc. announced the University of California, San Diego Health as the first hospital system in the world to offer its recently U.S. Food and Drug Administration - cleared vMap™.
-
Up to 40% of AD patients were found to have Lewy Bodies in their brain after succumbing to the disease.
-
With a $50 Million Gift, USC and UC San Diego Join Forces in Alzheimer's Research
1/24/2022
A joint gift to the University of Southern California and the University of California San Diego totaling $50 million from the Epstein Family Foundation will drive Alzheimer's research and accelerate the search for treatments and a cure.
-
Deaths from drug overdoses have been on an upward trajectory for years, but have experienced a notable increase since the early days of the COVID-19 pandemic.
-
An oral version of remdesivir is being developed by scientists at the University of California San Diego to combat the SARS-CoV-2 virus early in its infection cycle.
-
BridgeBio Pharma and the University of California, San Diego Announce Collaboration to Advance Treatments for Genetically Driven Conditions
4/13/2021
BridgeBio Pharma, Inc. (NASDAQ: BBIO), and the University of California, San Diego (UC San Diego) today announced a partnership to translate research in genetically driven conditions into potential therapeutic applications for patients, with a focus on oncology and neurology.
-
Global Cancer Technology Signs Agreement with Barrow Neurological Institute to Commercialize new Glioblastoma Treatment
4/2/2021
Together with scientists from the University of California San Diego , Global Cancer Technology (GCT) and the renowned Barrow Neurological Institute, pre-clinical studies have begun towards the commercialization of a new glioblastoma treatment.
-
Clinical Catch-Up: March 22-26
3/29/2021
There was a fair amount of clinical trial news last week. Here’s a look. -
Explore the Mapping of the Cosmos March 25 with Pioneering Astrophysicist James Gunn, Livestreamed from UC San Diego’s Kyoto Prize Symposium
3/18/2021
University of California San Diego will virtually host international leader in astrophysical sciences, Professor James E. Gunn on March 25, 4-5:30 p.m.-PDT, as part of the annual Kyoto Prize Symposium.
-
Public Invited to Free Livestreamed Lectures by Latest Kyoto Prize Laureates, March 24-25 (PDT)
3/18/2021
The Inamori Foundation and the Kyoto Symposium Organization announced a detailed schedule for the 20th annual Kyoto Prize Symposium, featuring unique educational events with two university co-hosts – University of California San Diego and Point Loma Nazarene University.